Professional Documents
Culture Documents
Full
Full
Full
Communicated by Roger A. Nicoll, University of California, San Francisco, CA, August 12, 2004 (received for review June 10, 2004)
Factors that control differentiation of presynaptic and postsynaptic for PSD-95 in the regulation of NLG-mediated effects in estab-
elements into excitatory or inhibitory synapses are poorly defined. lishing synaptic contacts. However, it remains unclear whether
Here we show that the postsynaptic density (PSD) proteins PSD-95 coordinated actions of NLG and PSD-95 dictate synapse specificity.
and neuroligin-1 (NLG) are critical for dictating the ratio of exci- Our data provide evidence that assembly of specific postsynaptic
tatory-to-inhibitory synaptic contacts. Exogenous NLG increased elements may not simply serve to form contacts between presyn-
both excitatory and inhibitory presynaptic contacts and the fre- aptic and postsynaptic compartments but can determine synapse
quency of miniature excitatory and inhibitory synaptic currents. In specificity. We find that the amounts of PSD-95 control proper
contrast, PSD-95 overexpression enhanced excitatory synapse size localization and兾or retention of NLG at the synapse, and that
and miniature frequency, but reduced the number of inhibitory coordinated actions of NLG and PSD-95 regulate type (excitatory
synaptic contacts. Introduction of PSD-95 with NLG augmented vs. inhibitory), number, and morphology of newly formed synaptic
synaptic clustering of NLG and abolished NLG effects on inhibitory contacts. These effects are manifested in an overall change in the
synapses. Interfering with endogenous PSD-95 expression alone ratio of excitatory兾inhibitory synaptic contact number and activity.
was sufficient to reduce the ratio of excitatory-to-inhibitory syn-
NEUROSCIENCE
apses. These findings elucidate a mechanism by which the amounts Methods
of specific elements critical for synapse formation control the ratio cDNA Cloning and Mutagenesis. Hemagglutinin (HA)-tagged WT
of excitatory-to-inhibitory synaptic input. NLG (1ab splice variant) amplified from mouse cerebellum was a
gift from Peter Scheiffele (Columbia University, New York).
HA-NLG was subcloned into pNice vector (Clontech), and the HA
S ynapse formation involves stabilization of initial sites of contact
between axons and dendrites, followed by recruitment of spe-
cific protein complexes to newly formed presynaptic and postsyn-
tag was inserted between amino acids 45 and 46 as described by
Scheiffele et al. (27). Generation of GW1 PSD-95 fused to GFP and
aptic structures (1–4). Neuronal contact formation is spatially and PSD-95 mutants has been described (15, 29). A NLG construct with
temporally controlled by changes in protein content and shape at a deletion of the last 4 aa (NLG⌬PDZb) and the other truncated
areas of contact (5, 6). The total number of synapses formed and forms of NLG lacking the C-terminal cytosolic domain (containing
ratio of excitatory-to-inhibitory synaptic inputs a neuron receives amino acids 1–730; NLG⌬CT GFP) or N-terminal extracellular
are factors critical for determining neuronal excitability. Appropri- sequences (containing amino acids 671–843; GFP NLG⌬NT) were
ate synthesis and recruitment of specific factors important for constructed by PCR and subcloned into an enhanced GFP vector
building synaptic contacts are thought to power this process. (Clontech). NLG⌬CT and NLG⌬NT constructs were tagged with
However, the identity of molecules that dictate the balance between GFP to allow detection of these proteins. The signal peptide of
excitatory and inhibitory synaptic contacts remains elusive. Several NLG (amino acids 1–46) was added to the N terminus of NLG⌬NT
lines of evidence indicate that the scaffolding postsynaptic density to maintain proper protein sorting.
(PSD) protein, PSD-95, is involved in orchestrating excitatory
synapse maturation and specificity (7). PSD-95 is exclusively local- Neuronal Cell Culture and Transfections. Dissociated primary neu-
ized to glutamatergic synapses (8). Moreover, PSD-95 expression ronal cultures were prepared from hippocampi of embryonic day
correlates with the period of excitatory synapse maturation (7, (E)18兾E19 Wistar rats as described (30). Cultures were maintained
9–11). Augmentation of excitatory synapse activity and ion channel in Neurobasal media (GIBCO-Invitrogen) supplemented with B27,
clustering is driven by PSD-95 but not by related proteins, including penicillin, streptomycin, and L-glutamine. Hippocampal cultures
synapse-associated protein (SAP)-102 and SAP-97 (12–14), and were transfected by lipid-mediated gene transfer 3 days before
PSD-95 regulates clustering and activity of the ␣-amino-3-hydroxy- immunostaining by using the transfection agent Effectene
5-methyl-4-isoxazolepropionic acid-type glutamate receptors (GIBCO-Invitrogen) as described (31) and according to the man-
through a direct interaction with stargazin (7, 13–20). However, it ufacturer’s protocol.
is unknown how PSD-95 effects are translated into changes in
apposing presynaptic terminals. A candidate molecule for mediat- Immunocytochemistry. Coverslips were removed from culture wells,
ing PSD-95 effects on presynaptic maturation is the cell adhesion fixed in ⫺20°C methanol, and immunolabeled for synaptic protein
molecule neuroligin (NLG). NLG is present at excitatory postsyn- as described (15, 29). The following primary antibodies were used:
aptic sites and associates with the third PSD-95兾Dlg兾ZO-1 homol- PSD-95 (mouse, 1:500; Affinity BioReagents, Golden, CO), GFP
ogy (PDZ) domain of PSD-95 through its C-terminal PDZ-binding (mouse, 1:1,000; Clontech), NLG (mouse, 1:1,000; Synaptic Sys-
site (2, 21, 22). tems, Goettingen, Germany), synaptophysin (rabbit, 1:1,000;
The postsynaptic PDZ protein S-SCAM, another known binding Pharmingen), vesicular ␥-aminobutyric acid (GABA) transporter
partner of NLG, is also possibly involved in modulating NLG effects
Downloaded at Technische Universitaet Braunschweig on February 2, 2022
neurexin protein interaction (26, 27). Moreover, coexpression of ‡T.P.W. and K.G. contributed equally to this work.
PSD-95 with NLG in heterologous cells potentiated NLG effects on §To whom correspondence should be addressed. E-mail: alaa@interchange.ubc.ca.
N-methyl-D-aspartic acid currents (28). These results support a role © 2004 by The National Academy of Sciences of the USA
2 mM MgCl2, 10 mM EGTA, 4 mM ATP, 0.4 mM GTP, and 0.1% of distinct clusters of HA-NLG may have resulted from insuf-
Lucifer yellow (Sigma-Aldrich). A MultiClamp 700A amplifier ficient amounts of endogenous PSD-95. To test this, we first
(Axon Instruments, Foster City, CA) was used for recording. examined whether PSD-95 GFP could drive clustering of en-
Access resistance was monitored, and recordings where series dogenous NLG. Using antibodies specific to NLG subtypes 1 and
resistance varied by ⬎10% were rejected. No electronic compen- 3, we found that the size of NLG clusters was significantly
sation for series resistance was used. Whole-cell patch-clamp re- enhanced (2.6- ⫾ 0.2-fold) at sites containing PSD-95 GFP (Fig.
cordings were performed in voltage-clamp mode while maintaining 2 A and B). The size of presynaptic contacts (labeled with
the membrane potential either at the reversal potential for GABA synaptophysin) was also enhanced (2.6- ⫾ 0.2-fold). Moreover,
truncated form of PSD-95 that contains only the first two PDZ
a linear correlation (P ⬍ 0.0001) between the size of PSD-95 domains (PSD-95 1-PDZ2). This mutant form was previously
GFP, NLG, and Syn clusters was seen at single synapses (n ⫽ 10 shown to enhance GluR1 clustering (14). However, we found
cells, 200 synapses). This analysis revealed that PSD-95- expression of PSD-95 1-PDZ2 did not significantly enhance either
mediated clustering of NLG and presynaptic enhancement are NLG clustering or the size of opposed presynaptic sites (Fig. 2 C and
tightly regulated at individual excitatory synapses. D). These results indicate that PSD-95-mediated clustering of
Previous findings showed that NLG associates with the third GluR1 and NLG involves two independent processes.
PDZ domain of PSD-95 through its C-terminal PDZ binding site Similar to the enhanced clustering of endogenous NLG, we also
Prange et al. PNAS 兩 September 21, 2004 兩 vol. 101 兩 no. 38 兩 13917
Fig. 3. PSD-95 restricts NLG localization to excitatory synapses. Cells trans-
fected with HA-NLG and PSD-95 GFP and stained with VGAT or VGLUT. (A
Right) Magnifications of Inset Left. (A and B) PSD-95 GFP recruited HA-NLG to
sites positive for VGLUT (n ⫽ 7 cells) but not VGAT (n ⫽ 10 cells). (C) Graph
summarizing these results. (D and E) GluR1 cluster size was enhanced in
dendrites from cells expressing PSD-95 GFP alone (n ⫽ 9 cells) or HA-NLG (n ⫽
Fig. 4. PDZ-dependent interactions regulate the morphology of synapses
8 cells; white arrowheads) when compared with GluR1 clusters from untrans-
induced by PSD-95 and NLG. (A and B) Neurons were transfected with PSD-95
fected controls (n ⫽ 10 cells). Expression of HA-NLG alone (n ⫽ 8 cells) did not
GFP and either WT HA-NLG or a mutant HA-NLG lacking the PDZ-binding site
enhance GluR1 clustering. **, P ⬍ 0.01; ***, P ⬍ 0.001 (Mann–Whitney U test).
(HA-NLG⌬PDZb) and immunostained as indicated. (A) Colocalization (white
(Scale bars: 10 m, A Left; 1 m, A Right, B, and D.)
arrowheads) of HA-NLG with PSD-95 GFP and apposed synaptophysin (Syn)-
labeled presynaptic terminals. (A1 and A2) Localization of HA-NLG clusters
and apposed presynaptic terminal to PSD-95 GFP. (B) HA-NLG⌬PDZb is not
found that coexpression of HA-NLG with PSD-95 increased the recruited to PSD-95 GFP clusters (white arrowheads). (C) The correlation
average size of HA-NLG clusters (1.5- ⫾ 0.1-fold), which correlated between the size of PSD-95 GFP, HA-NLG, and Syn clusters at single synaptic
with a reduction in the total number of presynaptic terminals (2.5- sites (linear fit; red line) was stronger in cells coexpressing PSD-95 GFP and WT
⫾ 0-fold) (Fig. 2 E–H). Notably, 85 ⫾ 3% of HA-NLG and PSD-95 HA-NLG (P ⬍ 0.0001; n ⫽ 10 cells, 219 clusters) when compared to cells
GFP coclusters were present at sites apposed to excitatory presyn- expressing PSD-95 GFP and HA-NLG⌬PDZb (P ⬍ 0.001; n ⫽ 10 cells, 225
aptic terminals (VGLUT-labeled) (Fig. 3 A–C). These sites were clusters). (Scale bars: 10 m, A and B; 1 m, A1, A2, B1, and B2.)
also positive for the excitatory postsynaptic receptor GluR1 (Fig.
3D). Consistent with the modest effect of NLG on postsynaptic
VGLUT-positive puncta relative to the total number of synapses
elements, HA-NLG did not potentiate PSD-95-mediated clustering
of GluR1 (Fig. 3E). Taken together, these results demonstrate that (Fig. 5). Expression of PSD-95 GFP resulted in a significant
PSD-95 controls NLG and GluR1 accumulation at postsynaptic reduction in number (2.5- ⫾ 0.1-fold) and size (1.5- ⫾ 0.1-fold) of
sites and restricts NLG clusters to excitatory synapses. HA-NLG-induced VGAT-positive contacts, to levels similar to
To further characterize the relationship between NLG and those of GFP-expressing controls (Fig. 5A Upper). In contrast,
PSD-95 in regulating synapse morphology, we compared correla- PSD-95 GFP did not alter the number or size of VGLUT-positive
tion of the presynaptic and postsynaptic contacts in neurons trans- terminals induced by HA-NLG (Fig. 5A Lower).
fected with PSD-95 and WT NLG or a mutant form of NLG lacking We next sought to examine functional correlates of these synaptic
the PDZ-binding domain (HA-NLG⌬PDZb) (Fig. 4). This analysis changes by using an electrophysiological approach (Fig. 5 B and C).
revealed that the shape of presynaptic and postsynaptic contacts We compared changes in excitatory and inhibitory currents in
was highly correlated only at sites coexpressing PSD-95 GFP and hippocampal neurons transfected with either GFP alone, HA-NLG
WT HA-NLG (Fig. 4C). This finding supports the notion that both and GFP, PSD-95 GFP, or PSD-95 GFP and HA-NLG by using
proteins influence presynaptic contact morphology. whole-cell voltage-clamp recordings of mEPSCs and mIPSCs.
Next, to prevent binding to extracellular partners, we replaced the Miniature frequency reflects both the size and number of presyn-
N-terminal domain (amino acids 46–694) of NLG with a sequence aptic contacts, whereas the average amplitude of miniature currents
coding for GFP (GFP NLG⌬NT) (Fig. 8, which is published as correlates with postsynaptic parameters (33). Ectopic expression of
supporting information on the PNAS web site). Clusters of GFP HA-NLG significantly increased the frequency of mEPSCs (2.1- ⫾
NLG⌬NT partially colocalized (to 43 ⫾ 5%) with PSD-95. At these 0.3-fold) and IPSCs (1.9- ⫾ 0.4-fold). A similar increase in mEPSC
sites, the number of synaptophysin-positive contacts was reduced frequency was observed in neurons expressing PSD-95 GFP with
Downloaded at Technische Universitaet Braunschweig on February 2, 2022
(by 86 ⫾ 4%). This finding indicates that coupling of these (1.8- ⫾ 0.3-fold) or without HA-NLG (2- ⫾ 0.4-fold). Moreover,
molecules may regulate synapse formation at sites containing HA-NLG enhanced the average amplitude of mEPSCs only when
PSD-95. coexpressed with PSD-95. This finding is consistent with the lack of
changes in GluR1 clustering upon overexpression of NLG. In
PSD-95 Modulates the Specificity of NLG-Induced Synapses. To test addition, HA-NLG induced an increase in mIPSC frequency that
whether PSD-95 modulates the specificity of HA-NLG-induced was abolished upon coexpression with PSD-95 GFP, a result
synapses, we evaluated the ratios of inhibitory and excitatory paralleling our immunocytochemical data. Strikingly, expression of
synaptic contacts by comparing the number of VGAT- and PSD-95 GFP alone resulted in a significant decrease (by 64 ⫾ 11%)
(n ⫽ 9), or GFP alone (controls, n ⫽ 16). Spontaneous mEPSCs (B) and mIPSCs Methods) (Fig. 6 B and C). Cotransfection of PSD-95 siRNA
(C) were measured at holding potentials of ⫺60 mV and ⫹10mV, respectively. together with GFP reduced PSD-95 clusters (by 56 ⫾ 5%). In
(B) Enhanced mEPSC frequency and amplitude in cells expressing PSD-95 GFP contrast, no change in the number of PSD-95 clusters was observed
and HA-NLG with PSD-95 GFP. Enhancement of mEPSC frequency, but not of
in neurons expressing a scrambled siRNA (Fig. 6B). Expression of
amplitude, in cells expressing HA-NLG with GFP is shown. (C) mIPSC frequency
was enhanced in cells expressing HA-NLG with GFP, reduced in cells expressing PSD-95 siRNA also resulted in an increase (1.5- ⫾ 0.1-fold) in
PSD-95 GFP, and unchanged in cells expressing HA-NLG with PSD-95 GFP. No inhibitory (VGAT-positive) and a decrease (by 28 ⫾ 7%) in
difference in the average mIPSC amplitude between cell groups was found. excitatory (VGAT-negative) synaptic contacts. However, no
*, P ⬍ 0.05; **, P ⬍ 0.01; ***, P ⬍ 0.001 (Mann–Whitney U test). change in total number of synaptic contacts was observed (Fig. 6C).
Prange et al. PNAS 兩 September 21, 2004 兩 vol. 101 兩 no. 38 兩 13919
These results demonstrate that the amounts of PSD-95 available sponses, leading to the structural reorganization of the presynaptic
can dictate the balance between excitatory and inhibitory presyn- compartment. However, it remains unclear whether specific neur-
aptic inputs. exin isoforms are present at GABAergic presynaptic terminals and
In conclusion, our results show a striking difference between the whether an interaction between NLG and neurexin mediates the
effects of PSD-95 and NLG in dictating synaptic identity. Whereas effects we observed on inhibitory presynaptic sites.
NLG expression results in a dramatic increase of both excitatory The importance of our findings is emphasized by the recent
and inhibitory presynaptic contacts, PSD-95 selectively induces discovery that frameshift mutations in NLG3 and NLG4 genes,
maturation of excitatory presynaptic and postsynaptic elements. which result in early protein truncation and misfolding, are asso-
PSD-95, by recruiting NLG at sites of contact, plays a decisive role ciated with autism (38–41). Moreover, chromosomal rearrange-
in controlling synaptic contact number, morphology, and specific- ments that harbor NLG1 and NLG2 and PSD-95 genes have been
ity. In contrast, the lack of specificity of synapses induced by NLG associated with autism (42–44). Abnormal expression of PSD-95 is
suggests that NLG is strictly involved in establishing initial synaptic also altered in fragile-X syndrome (45). We propose a model in
contacts regardless of their phenotype. The identity of these which improper expression and兾or targeting of molecules that
contacts may be determined by events that require the recruitment control synaptic specificity, such as PSD-95 and NLG, may trigger
of additional factors. This study reveals that PSD-95 is one of the an imbalance in neuronal excitability. This model is supported by
potential factors involved in this process. By assembling a core our finding that manipulation of endogenous PSD-95 alone was
postsynaptic complex containing stargazin, ␣-amino-3-hydroxy-5- sufficient to alter the ratio of excitatory兾inhibitory synaptic con-
methyl-4-isoxazolepropionic acid receptor, and GKAP, PSD-95 tacts. This notion is consistent with a recent model suggesting that
may determine synaptic identity (34). the ratio of neuronal excitation兾inhibition is altered in psychiatric
disorders, specifically in autism and mental retardation (46).
How does NLG communicate with excitatory and inhibitory
presynaptic elements? A known binding partner of NLG is -neur-
We thank Dr. Tim Murphy and Pamela Arstikaitis for valuable sugges-
exin, a neuron-specific cell surface protein that exists in several tions and discussions. This work was supported by grants from the
alternatively spliced isoforms (22, 27, 35, 36). Similar to NLG, Canadian Institutes for Health Research, the Michael Smith Foundation
neurexins also contain PDZ-binding motifs that bind to type II for Health Research, and the EJLB Foundation (to A.E.-H.). A.E.-H. is
PDZ domains present in CASK and syntenin but not PSD-95. The a Canadian Institutes for Health Research New Investigator and a
association of -neurexin to a tripartite protein complex formed of Michael Smith Foundation for Health Research Scholar. Y.T.W. is a
CASK, Mint-1, and Veli has been proposed to act as a nucleation Canadian Institutes for Health Research Investigator and a Howard
Hughes Medical Institute International Research Scholar. O.P. is sup-
site for coupling cell adhesion molecules to synaptic vesicle exocy-
ported by a postdoctoral fellowship from the Bluma-Tischler Founda-
tosis (36). Also, neurexins are directly coupled to synaptotagmins, tion. K.G. is supported by a Michael Smith Foundation for Health
core molecules of the synaptic vesicle machinery that regulate Research Junior Trainee Fellowship. T.P.W. is supported by Canadian
neurotransmitter exocytosis (37). Therefore, binding of NLG to Institutes for Health Research and Michael Smith Foundation for Health
-neurexin may activate an array of presynaptic molecular re- Research postdoctoral fellowships.
1. Zhai, R. G., Vardinon-Friedman, H., Cases-Langhoff, C., Becker, B., Gun- 24. Missler, M. & Sudhof, T. C. (1998) Trends Genet. 14, 20–26.
delfinger, E. D., Ziv, N. E. & Garner, C. C. (2001) Neuron 29, 131–143. 25. Rao, A., Harms, K. J. & Craig, A. M. (2000) Nat. Neurosci. 3, 747–749.
2. Brose, N. (1999) Naturwissenschaften 86, 516–524. 26. Dean, C., Scholl, F. G., Choih, J., DeMaria, S., Berger, J., Isacoff, E. &
3. Ziv, N. E. (2001) Neuroscientist 7, 365–370. Scheiffele, P. (2003) Nat. Neurosci. 6, 708–716.
4. Shapira, M., Zhai, R. G., Dresbach, T., Bresler, T., Torres, V. I., Gundelfinger, 27. Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. (2000) Cell 101, 657–669.
E. D., Ziv, N. E. & Garner, C. C. (2003) Neuron 38, 237–252. 28. Fu, Z., Washbourne, P., Ortinski, P. & Vicini, S. (2003) J. Neurophysiol. 90,
5. Lee, S. H. & Sheng, M. (2000) Curr. Opin. Neurobiol. 10, 125–131. 3950–3957.
6. Craig, A. M. & Boudin, H. (2001) Nat. Neurosci. 4, 569–578. 29. El-Husseini, A. E., Craven, S. E., Chetkovich, D. M., Firestein, B. L., Schnell,
7. El-Husseini, A. E., Schnell, E., Chetkovich, D. M., Nicoll, R. A. & Bredt, D. S. E., Aoki, C. & Bredt, D. S. (2000) J. Cell Biol. 148, 159–172.
(2000) Science 290, 1364–1368. 30. Gauthier-Campbell, C., Bredt, D. S., Murphy, T. H. & El-Husseini, A. (2004)
8. Hunt, C. A., Schenker, L. J. & Kennedy, M. B. (1996) J. Neurosci. 16, Mol. Biol. Cell 15, 2205–2217.
1380–1388. 31. Kanaani, J., El-Husseini A., D., Aguilera-Moreno, A., Diacovo, J. M., Bredt,
9. Petralia, R. S., Esteban, J. A., Wang, Y. X., Partridge, J. G., Zhao, H. M., D. S. & Baekkeskov, S. (2002) J. Cell Biol. 158, 1229–1238.
Wenthold, R. J. & Malinow, R. (1999) Nat. Neurosci. 2, 31–36. 32. Song, J. Y., Ichtchenko, K., Sudhof, T. C. & Brose, N. (1999) Proc. Natl. Acad.
10. Sans, N., Petralia, R. S., Wang, Y. X., Blahos, J., II, Hell, J. W. & Wenthold, Sci. USA 96, 1100–1105.
R. J. (2000) J. Neurosci. 20, 1260–1271. 33. Prange, O. & Murphy, T. H. (1999) J. Neurosci. 19, 6427–6438.
11. Rao, A., Kim, E., Sheng, M. & Craig, A. M. (1998) J. Neurosci. 18, 1217–1229. 34. Bredt, D. S. & Nicoll, R. A. (2003) Neuron 40, 361–379.
12. El-Husseini, A. E., Topinka, J. R., Lehrer-Graiwer, J. E., Firestein, B. L., 35. Ichtchenko, K., Nguyen, T. & Südhof, T. C. (1996) J. Biol. Chem. 271, 2676–2682.
Craven, S. E., Aoki, C. & Bredt, D. S. (2000) J. Biol. Chem. 275, 23904–23910. 36. Butz, S., Okamoto, M. & Sudhof, T. C. (1998) Cell 94, 773–782.
13. Ehrlich, I. & Malinow, R. (2004) J. Neurosci. 24, 916–927. 37. Hata, Y., Davletov, B., Petrenko, A. G., Jahn, R. & Sudhof, T. C. (1993) Neuron
14. Schnell, E., Sizemore, M., Karimzadegan, S., Chen, L., Bredt, D. S. & Nicoll, 10, 307–315.
R. A. (2002) Proc. Natl. Acad. Sci. USA 99, 13902–13907. 38. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I. C.,
15. Craven, S. E., El-Husseini, A. E. & Bredt, D. S. (1999) Neuron 22, 497–509. Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C., et al. (2003) Nat. Genet.
16. El-Husseini, A. E., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q., Prange, O., 34, 27–29.
Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R. A. & Bredt, D. S. 39. Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A.,
(2002) Cell 108, 849–863. Moizard, M. P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P., et al. (2004)
17. Beique, J. C. & Andrade, R. (2003) J. Physiol. (London) 546, 859–867. Am. J. Hum. Genet. 74, 552–557.
18. Losi, G., Prybylowski, K., Fu, Z., Luo, J., Wenthold, R. J. & Vicini, S. (2003) 40. Comoletti, D., De Jaco, A., Jennings, L. L., Flynn, R. E., Gaietta, G., Tsigelny,
J. Physiol. (London) 548, 21–29. I., Ellisman, M. H. & Taylor, P. (2004) J. Neurosci. 24, 4889–4893.
19. Chen, L., Chetkovich, D. M., Petralia, R. S., Sweeney, N. T., Kawasaki, Y., 41. Chih, B., Afridi, S. K., Clark, L. & Scheiffele, P. (2004) Hum. Mol. Genet. 13,
Downloaded at Technische Universitaet Braunschweig on February 2, 2022
Wenthold, R. J., Bredt, D. S. & Nicoll, R. A. (2000) Nature 408, 936–943. 1471–1477.
20. Stein, V., House, D. R., Bredt, D. S. & Nicoll, R. A. (2003) J. Neurosci. 23, 42. Auranen, M., Vanhala, R., Varilo, T., Ayers, K., Kempas, E., Ylisaukko-Oja, T.,
5503–5506. Sinsheimer, J. S., Peltonen, L. & Jarvela, I. (2002) Am. J. Hum. Genet. 71, 777–790.
21. Ichtchenko, K., Hata, Y., Nguyen, T., Ullrich, B., Missler, M., Moomaw, C. & 43. Konstantareas, M. M. & Homatidis, S. (1999) J. Autism Dev. Disord. 29,
Sudhof, T. C. (1995) Cell 81, 435–443. 275–285.
22. Irie, M., Hata, Y., Takeuchi, M., Ichtchenko, K., Toyoda, A., Hirao, K., Takai, 44. Zoghbi, H. Y. (2003) Science 302, 826–830.
Y., Rosahl, T. W. & Sudhof, T. C. (1997) Science 277, 1511–1515. 45. Todd, P. K., Mack, K. J. & Malter, J. S. (2003) Proc. Natl. Acad. Sci. USA 100,
23. Hirao, K., Hata, Y., Ide, N., Takeuchi, M., Irie, M., Yao, I., Deguchi, M., 14374–14378.
Toyoda, A., Sudhof, T. C. & Takai, Y. (1998) J. Biol. Chem. 273, 21105–21110. 46. Rubenstein, J. L. & Merzenich, M. M. (2003) Genes Brain Behav. 2, 255–267.